首页 | 本学科首页   官方微博 | 高级检索  
     


Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)
Authors:Michael Montemurro MD  Angela Cioffi MD  Julien Dômont MD  Piotr Rutkowski MD  Arnaud D. Roth MD  Roger von Moos MD  Roman Inauen MD  Maud Toulmonde MD  Roger O. Burkhard MD  Claudio Knuesli MD  Sebastian Bauer MD  Philippe Cassier MD  Heike Schwarb MD  Axel Le Cesne MD  Dieter Koeberle MD  Daniela Bärtschi CPM  Daniel Dietrich Statistician  Christine Biaggi CPM  John Prior MD  Serge Leyvraz MD
Affiliation:1. Medical Oncology, University Hospital of Lausanne, Lausanne, Switzerland;2. Medical Oncology‐Sarcoma, Gustave Roussy Institute, Villejuif, France;3. Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska‐Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland;4. Division of Oncology, Geneva University Hospital, Geneva, Switzerland;5. Medical Oncology and Hematology, Cantonal Hospital Graubunden, Chur, Switzerland;6. Department of Oncology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland;7. Medical Oncology, Bergonie Institute, Bordeaux, France;8. Oncology Center, Hirslanden Hospital and Health Care, Zurich, Switzerland;9. Medical Oncology, Hospital St. Claraspital, Basel, Switzerland;10. Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University of Duisburg‐Essen, Essen, Germany;11. Oncology, Leon Berard Center, Lyon, France;12. Oncology/Internal Medicine, Cantonal Hospital Baden, Baden, Switzerland;13. Department of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland;14. Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland;15. Nuclear Medicine and Molecular Imaging, University Hospital of Lausanne, Lausanne, Switzerland
Abstract:
Keywords:18F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET)  dasatinib  gastrointestinal stromal tumor (GIST)  imatinib  positron emission tomography (PET)  sunitinib  tyrosine kinase inhibitor (TKI)  PET  FDG‐PET
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号